Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply to M. Sorigue et al.
MacManus M, Fisher R, McClure B, Seymour JF. MacManus M, et al. Among authors: mcclure b. J Clin Oncol. 2019 Jan 20;37(3):257-258. doi: 10.1200/JCO.2018.18.01309. Epub 2018 Nov 26. J Clin Oncol. 2019. PMID: 30475669 No abstract available.
Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.
Ngan SY, Burmeister B, Fisher RJ, Solomon M, Goldstein D, Joseph D, Ackland SP, Schache D, McClure B, McLachlan SA, McKendrick J, Leong T, Hartopeanu C, Zalcberg J, Mackay J. Ngan SY, et al. Among authors: mcclure b. J Clin Oncol. 2012 Nov 1;30(31):3827-33. doi: 10.1200/JCO.2012.42.9597. Epub 2012 Sep 24. J Clin Oncol. 2012. PMID: 23008301 Clinical Trial.
Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02).
Rischin D, Peters L, Fisher R, Macann A, Denham J, Poulsen M, Jackson M, Kenny L, Penniment M, Corry J, Lamb D, McClure B. Rischin D, et al. Among authors: mcclure b. J Clin Oncol. 2005 Jan 1;23(1):79-87. doi: 10.1200/JCO.2005.01.072. J Clin Oncol. 2005. PMID: 15625362 Clinical Trial.
Response to Dahele and Senan.
Ball D, Fisher R, McClure B; TROG 99.05 investigators. Ball D, et al. Among authors: mcclure b. Radiother Oncol. 2013 Oct;109(1):180-1. doi: 10.1016/j.radonc.2013.08.039. Epub 2013 Oct 12. Radiother Oncol. 2013. PMID: 24128807 No abstract available.
The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: a prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05).
Ball DL, Fisher RJ, Burmeister BH, Poulsen MG, Graham PH, Penniment MG, Vinod SK, Krawitz HE, Joseph DJ, Wheeler GC, McClure BE. Ball DL, et al. Radiother Oncol. 2013 Mar;106(3):305-11. doi: 10.1016/j.radonc.2012.12.003. Epub 2013 Jan 16. Radiother Oncol. 2013. PMID: 23333017
Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).
Ansari N, Solomon MJ, Fisher RJ, Mackay J, Burmeister B, Ackland S, Heriot A, Joseph D, McLachlan SA, McClure B, Ngan SY. Ansari N, et al. Among authors: mcclure b. Ann Surg. 2017 May;265(5):882-888. doi: 10.1097/SLA.0000000000001987. Ann Surg. 2017. PMID: 27631775 Clinical Trial.
The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04).
McLachlan SA, Fisher RJ, Zalcberg J, Solomon M, Burmeister B, Goldstein D, Leong T, Ackland SP, McKendrick J, McClure B, Mackay J, Ngan SY. McLachlan SA, et al. Among authors: mcclure b. Eur J Cancer. 2016 Mar;55:15-26. doi: 10.1016/j.ejca.2015.10.060. Epub 2016 Jan 7. Eur J Cancer. 2016. PMID: 26771873 Clinical Trial.
193 results